Novo Nordisk hit my target this week and I have started to buy
The head and shoulders pattern successfully played out, with 
NOVO_B reaching my full target at 670.
Check out my original post:
The stock experienced a significant drop, falling as much as 27% on the Friday before Christmas. This was triggered by test results for their obesity drug, CagriSema, which showed patient weight loss of 22.7% - below the anticipated 25%.
I believe this reaction is an overcorrection and have taken advantage of this rare opportunity to purchaseNOVO_B, first at 680 and again at 600. I now plan to hold patiently, expecting Novo Nordisk to reach new all-time highs in the coming years.
NOVO_B reaching my full target at 670.Check out my original post:
The stock experienced a significant drop, falling as much as 27% on the Friday before Christmas. This was triggered by test results for their obesity drug, CagriSema, which showed patient weight loss of 22.7% - below the anticipated 25%.
I believe this reaction is an overcorrection and have taken advantage of this rare opportunity to purchase
NOVO_B, first at 680 and again at 600. I now plan to hold patiently, expecting Novo Nordisk to reach new all-time highs in the coming years.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.